{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:44:49Z","timestamp":1770817489804,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Education, Science and Technological development of Serbia","award":["OI175096"],"award-info":[{"award-number":["OI175096"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s13105-016-0514-4","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T22:21:43Z","timestamp":1471472503000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive rats"],"prefix":"10.1007","volume":"72","author":[{"given":"Zoran","family":"Miloradovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0110ur\u0111ica","family":"Jovovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Karanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Una Jovana","family":"Vaji\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmina","family":"Markovi\u0107-Lipkovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevena","family":"Mihailovi\u0107-Stanojevi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelica Gruji\u0107","family":"Milanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"514_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/808726","volume":"2012","author":"LC Barroso","year":"2012","unstructured":"Barroso LC, Silveira KD, Lima CX, Borges V, Bader M, Rachid M, et al. (2012) Renoprotective effects of AVE0991, a nonpeptide mas receptor agonist, in experimental acute renal injury. Int J Hypertens 2012:808726. doi: 10.1155\/2012\/808726","journal-title":"Int J Hypertens"},{"key":"514_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40697-015-0044-y","volume":"2","author":"M Bedford","year":"2015","unstructured":"Bedford M, Farmer CKT, Irving J, Stevens PE (2015) Acute kidney injury: an acceptable risk of treatment with renin-angiotensin system blockade in primary care? Canadian Journal of Kidney Health and Disease 2:14. doi: 10.1186\/s40697-015-0044-y","journal-title":"Canadian Journal of Kidney Health and Disease"},{"key":"514_CR3","first-page":"H2337","volume":"281","author":"C Berry","year":"2001","unstructured":"Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Phys 281:H2337\u2013H2365","journal-title":"Am J Phys"},{"key":"514_CR4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.HYP.0000174602.59935.d5","volume":"46","author":"RJ Bolterman","year":"2005","unstructured":"Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC (2005) Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46:943\u2013947","journal-title":"Hypertension"},{"key":"514_CR5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/er.2003-0001","volume":"24","author":"RM Carey","year":"2003","unstructured":"Carey RM, Siragy HM (2003) Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal disease. Endocr Rev 24:261\u2013271","journal-title":"Endocr Rev"},{"key":"514_CR6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.HYP.0000159192.93968.8f","volume":"45","author":"RM Carey","year":"2005","unstructured":"Carey RM (2005) Cardiovascular and renal regulation by the angiotensin type 2 receptor: the AT2 receptor comes of age. Hypertension 45:840\u2013844","journal-title":"Hypertension"},{"key":"514_CR7","doi-asserted-by":"crossref","first-page":"17985","DOI":"10.1073\/pnas.0605545103","volume":"103","author":"SD Crowley","year":"2006","unstructured":"Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, et al. (2006) Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103:17985\u201317990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"514_CR8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M Gasparo de","year":"2000","unstructured":"de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415\u2013472","journal-title":"Pharmacol Rev"},{"key":"514_CR9","volume":"8","author":"F Fang","year":"2013","unstructured":"Fang F, Liu GC, Zhou X, Yang S, Reich HN, et al. (2013) Loss of ACE2 exacerbates murine renal ischemia-reperfusion injury. PLoS One 8:e71433","journal-title":"PLoS One"},{"key":"514_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e3283406f57","volume":"20","author":"CM Ferrario","year":"2011","unstructured":"Ferrario CM (2011) ACE2: more of Ang-(1\u20137) or less Ang II? Curr Opin Nephrol Hypertens 20:1\u20136","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"514_CR11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.RES.46.3.440","volume":"46","author":"WF Finn","year":"1980","unstructured":"Finn WF (1980) Enhanced recovery from postischemic acute renal failure. Micropuncture studies in the rat. Circ Res 46:440\u2013448","journal-title":"Circ Res"},{"key":"514_CR12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1681\/ASN.V113454","volume":"11","author":"G Gobe","year":"2000","unstructured":"Gobe G, Zhang XJ, Willgoss DA, Schoch E, Hogg NA, et al. (2000) Relationship between expression of Bcl-2 genes and growth factors in ischemic acute renal failure in the rat. J Am Soc Nephrol 11:454\u2013467","journal-title":"J Am Soc Nephrol"},{"key":"514_CR13","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00294.2003","volume":"286","author":"N Hashimoto","year":"2004","unstructured":"Hashimoto N, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H (2004) Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 286:F516\u2013F525","journal-title":"Am J Physiol Renal Physiol"},{"key":"514_CR14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000325457","volume":"87","author":"GH Heeba","year":"2011","unstructured":"Heeba GH (2011) Angiotensin II receptor blocker, losartan, ameliorates gentamicin-induced oxidative stress and nephrotoxicity in rats. Pharmacology 87:232\u2013240","journal-title":"Pharmacology"},{"key":"514_CR15","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.1993.78","volume":"43","author":"N Honda","year":"1993","unstructured":"Honda N, Hishida A (1993) Pathophysiology of experimental nonoliguric acute renal failure. Kidney Int 43:513\u2013521","journal-title":"Kidney Int"},{"key":"514_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cbf.953","volume":"20","author":"M Inal","year":"2002","unstructured":"Inal M, Altinisik M, Bilgin MD (2002) The effect of quercetin on renal ischemia and reperfusion injury in the rat. Cell Biochem Funct 20:291\u2013296","journal-title":"Cell Biochem Funct"},{"key":"514_CR17","first-page":"583","volume":"4","author":"I Ishikawa","year":"1991","unstructured":"Ishikawa I, Harris RC (1991) Angiotensin actions in the kidney: renewed insights into the old hormone. Kidney Int 4:583\u2013596","journal-title":"Kidney Int"},{"key":"514_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096353","author":"M Ivanov","year":"2014","unstructured":"Ivanov M, Mihailovi\u0107-Stanojevi\u0107 N, Gruji\u0107 Milanovi\u0107 J, Jovovi\u0107 \u0110, Markovi\u0107-Lipkovski J, \u0106irovi\u0107 S, Miloradovi\u0107 Z (2014) Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney. PLoS One. doi: 10.1371\/journal.pone.0096353","journal-title":"PLoS One"},{"key":"514_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/APhysiol.98.2011.1.1","volume":"98","author":"M Ivanov","year":"2011","unstructured":"Ivanov M, Mihailovi\u0107-Stanojevi\u0107 N, Gruji\u0107 Milanovi\u0107 J, Jovovi\u0107 \u0110, Miloradovi\u0107 Z (2011) Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure. Acta Physiol Hung 98:1\u20137","journal-title":"Acta Physiol Hung"},{"key":"514_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai M, Horiuchi M (2009) Devil and angel in the renin\u2013angiotensin system: ACE\u2013angiotensin II\u2013AT1 receptor axis vs. ACE2\u2013angiotensin-(1\u20137)\u2013mas receptor axis. Hypertens Res 32:533\u2013536","journal-title":"Hypertens Res"},{"key":"514_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ndt\/gfg521","volume":"19","author":"M Jerki\u0107","year":"2004","unstructured":"Jerki\u0107 M, Miloradovi\u0107 Z, Jovovi\u0107 D, Mihailovi\u0107-Stanojevi\u0107 N, Elena JV, Nasti\u0107-Miri\u0107 D, Gruji\u0107-Adanja G, Rodriguez-Barbero A, Markovi\u0107-Lipkovski J, Vojvodi\u0107 SB, Manero MV, Prieto MP, Lopez-Novoa JM (2004) Relative roles of endothelin-1 and angiotensin II in experimental post-ischaemic acute renal failure. Nephrol Dial Transplant 19:83\u201394","journal-title":"Nephrol Dial Transplant"},{"key":"514_CR22","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/ndt\/14.6.1398","volume":"14","author":"M Jerki\u0107","year":"1999","unstructured":"Jerki\u0107 M, Varagi\u0107 J, Jovovi\u0107 \u0110, Radujkovi\u0107-Kuburovi\u0107 G, Nasti\u0107-Miri\u0107 D, Adanja-Gruji\u0107 G, Markovi\u0107-Lipkovski J, Dimitrijevi\u0107 J, Miloradovi\u0107 Z, Vojvodi\u0107 SB (1999) L-arginine reduces tubular cell injury in acute postischemic renal failure. Nephrol Dial Transplant 14:1398\u20131407","journal-title":"Nephrol Dial Transplant"},{"key":"514_CR23","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2008.08.009","volume":"120","author":"ES Jones","year":"2008","unstructured":"Jones ES, Vinh A, McCarthy CA, Gaspari TA, Widdop RE (2008) AT2 receptors: functional relevance in cardiovascular disease. Pharmacol Ther 120:292\u2013316","journal-title":"Pharmacol Ther"},{"key":"514_CR24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1681\/ASN.V112301","volume":"11","author":"M Kakoki","year":"2000","unstructured":"Kakoki M, Hirata Y, Hayakawa H, Suzuki E, Nagata D, Tojo A, Nishimatsu H, Nakanishi N, Hattori Y, Kikuchi K, Nagano T, Omata M (2000) Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 11:301\u2013309","journal-title":"J Am Soc Nephrol"},{"key":"514_CR25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1081\/JDI-100100859","volume":"22","author":"SJ Kim","year":"2000","unstructured":"Kim SJ, Lim YT, Kim BS, et al. (2000) Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Renal Fail 22:129\u2013141","journal-title":"Renal Fail"},{"key":"514_CR26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","volume":"42","author":"KK Koh","year":"2003","unstructured":"Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, et al. (2003) Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 42:905\u2013910","journal-title":"J Am Coll Cardiol"},{"key":"514_CR27","first-page":"F79","volume":"274","author":"J Kontogiannis","year":"1998","unstructured":"Kontogiannis J, Burns KD (1998) Role of AT1 angiotensin II receptors in renal ischemic injury. Am J Phys 274:F79\u2013F90","journal-title":"Am J Phys"},{"key":"514_CR28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0022-3565(24)37904-2","volume":"287","author":"Y Matsumura","year":"1998","unstructured":"Matsumura Y, Nishiura M, Deguchi S, Hashimoto N, Ogawa T, Seo R (1998) Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol ExpTher 287:1084\u20131091","journal-title":"J Pharmacol ExpTher"},{"key":"514_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(75)92376-4","volume":"1","author":"GJ Miller","year":"1975","unstructured":"Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet 1:16\u201319","journal-title":"Lancet"},{"key":"514_CR30","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/ndt\/gfm213","volume":"22","author":"Z Miloradovi\u0107","year":"2007","unstructured":"Miloradovi\u0107 Z, Jerki\u0107 M, Jovovi\u0107 \u0110, Mihailovi\u0107-Stanojevi\u0107 N, Gruji\u0107 Milanovi\u0107 J, et al. (2007) Bosentan and losartan ameliorate acute renal failure associated with mild but not strong NO blockade. Nephrol Dial Transplant 22:2476\u20132484","journal-title":"Nephrol Dial Transplant"},{"key":"514_CR31","doi-asserted-by":"crossref","first-page":"F437","DOI":"10.1152\/ajprenal.1999.277.3.F437","volume":"277","author":"N Miyata","year":"1999","unstructured":"Miyata N, Park F, Li XF, Cowley AW Jr (1999) Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol Renal Physiol 277:F437\u2013F446","journal-title":"Am J Physiol Renal Physiol"},{"key":"514_CR32","first-page":"S189","volume":"10","author":"LG Navar","year":"1999","unstructured":"Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, Mitchell KD (1999) Concentrations and actions of intraluminal angiotensin II. J Am Soc Nephrol 10:S189\u2013S195","journal-title":"J Am Soc Nephrol"},{"key":"514_CR33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/01.HYP.30.5.1238","volume":"30","author":"R Ozono","year":"1997","unstructured":"Ozono R, Wang Z-Q, Moore AF, Inagami T, Siragy HM, Carey RM (1997) Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30:1238\u20131246","journal-title":"Hypertension"},{"key":"514_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","volume":"465","author":"SH Padia","year":"2013","unstructured":"Padia SH, Carey RM (2013) AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function. Pflugers Arch 465:99\u2013110","journal-title":"Pflugers Arch"},{"key":"514_CR35","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916\u20131923","journal-title":"J Clin Invest"},{"key":"514_CR36","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1097\/01.ASN.0000096784.86791.21","volume":"14","author":"E Ritz","year":"2003","unstructured":"Ritz E, Haxsen V (2003) Angiotensin II and oxidative stress: an unholy alliance. J Am Soc Nephrol 14:2985\u20132987","journal-title":"J Am Soc Nephrol"},{"key":"514_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00345-010-0543-5","volume":"29","author":"S Silici","year":"2011","unstructured":"Silici S, Ekmekcioglu O, Kanbur M, Deniz K (2011) The protective effect of royal jelly against cisplatin-induced renal oxidative stress in rats. World J Urol 29:127\u2013132","journal-title":"World J Urol"},{"key":"514_CR38","first-page":"F171","volume":"234","author":"HJ Stein","year":"1978","unstructured":"Stein HJ, Lifschitz DM, Barnes BL (1978) Current concepts on the pathophysiology of acute renal failure. Am J Phys 234:F171\u2013F181","journal-title":"Am J Phys"},{"key":"514_CR39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejphar.2009.01.040","volume":"607","author":"F Therrien","year":"2009","unstructured":"Therrien F, Lemieux P, Belanger S, Agharazii M, Lebel M, et al. (2009) Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. Eur J Pharmacol 607:126\u2013134","journal-title":"Eur J Pharmacol"},{"key":"514_CR40","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/01.ASN.0000075552.97794.8C","volume":"14","author":"C Thiemermann","year":"2003","unstructured":"Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, et al. (2003) High density lipoprotein (HDL) reduces renal ischemia\/reperfusion injury. J Am Soc Nephrol 14:1833\u20131843","journal-title":"J Am Soc Nephrol"},{"key":"514_CR41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/MNH.0b013e328341164a","volume":"20","author":"C Tikellis","year":"2011","unstructured":"Tikellis C, Bernardi S, Burns WC (2011) Angiotensin converting enzyme 2 is a key modulator of the renin\u2013angiotensin system in cardiovascular and renal disease. Curr Opin Nephrol Hypertens 20:62\u201368","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"514_CR42","doi-asserted-by":"crossref","first-page":"F207","DOI":"10.1152\/ajprenal.00216.2004","volume":"288","author":"E Vazquez","year":"2005","unstructured":"Vazquez E, Coronel I, Bautista R, Romo E, Villalon CM, Avila-Casado MC, Soto V, Escalante B (2005) Angiotensin II-dependent induction of AT(2) receptor expression after renal ablation. Am J Physiol Renal Physiol 288:F207\u2013F213","journal-title":"Am J Physiol Renal Physiol"},{"key":"514_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2013.08.038","volume":"718","author":"Z Wang","year":"2013","unstructured":"Wang Z, Liu Y, Han Y, Guan W, Kou X, Fu J, et al. (2013) Protective effects of aliskiren on ischemia\u2013reperfusion-induced renal injury in rats. Eur J Pharmacol 718:160\u2013166","journal-title":"Eur J Pharmacol"},{"key":"514_CR44","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ndt\/gfh727","volume":"20","author":"G Wolf","year":"2005","unstructured":"Wolf G, Wenzel U, Jablonski K, Brundert M, Rinninger F (2005) Angiotensin II down-regulates the SR-BI HDL receptor in proximal tubular cells. Nephrol Dial Transplant 20:1222\u20131227","journal-title":"Nephrol Dial Transplant"},{"key":"514_CR45","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","volume":"32","author":"AM Zafari","year":"1998","unstructured":"Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, et al. (1998) Role of NADH\/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 32:488\u2013495","journal-title":"Hypertension"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-016-0514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13105-016-0514-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-016-0514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:57:55Z","timestamp":1749063475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13105-016-0514-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1007\/s13105-016-0514-4","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}